SHANNON GREGOREK: Open Payments
NPI 1790929099 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,340 in 134 payments from 34 companies in 2025. Trend: 2023 $3,064 · 2024 $2,677 · 2025 $3,340
Food & beverage: $2,940Speaker / faculty: $400
| Company | Payments | Amount |
|---|---|---|
| Senseonics, Incorporated | 1 | $400 |
| Novo Nordisk Inc | 13 | $334 |
| Corcept Therapeutics | 14 | $273 |
| Novartis Pharmaceuticals Corporation | 9 | $206 |
| CeQur Corporation | 1 | $182 |
| Amgen Inc. | 13 | $182 |
| Mannkind Corporation | 10 | $178 |
| Lilly USA, LLC | 9 | $171 |
| SANOFI-AVENTIS U.S. LLC | 5 | $125 |
| Madrigal Pharmaceuticals | 4 | $117 |
Products named: Eversense, Korlym, LEQVIO, CeQur Simplicity, AFREZZA, Ozempic, TZIELD, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
